Our Senior Vice-President, Sandy Munro contributed to a roundtable article on Pharmaceutical Technology’s website entitled “The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery”. The article is focused on the new molecules in development and on how they will challenge drug delivery.
“Historically, the inhalation space was dominated by small-molecule therapies for moderate asthma and chronic obstructive pulmonary disease treatments. These days, the interest is much broader both in terms of the diseases that the developers are interested in, and also the range of molecule types.”
You can read the full article here.